Maxipime Cefepime 1g Injection Retail Pack from Japan
Branded Maxipime cefepime hydrochloride 1g powder in a retail-ready carton with diluent syringe for hospital use against resistant infections. It qualifies for HTS 3004.20.00.71 as a mixed/unmixed cefepime salt product in measured doses for therapeutic prophylactic uses. Packaging is designed for direct retail sale.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include branded labeling and PIL (patient information leaflet) equivalents for FDA import review
• Verify tariff shift rules if manufactured in FTZ; document cefepime content > principal ingredient
• Watch for misdeclaration as bulk chemical, ensuring retail packing proofs